Trimtabs Asset Management adds AmerisourceBergen Corp. (ABC) to its portfolio

AmerisourceBergen Corp. (ABC) : Trimtabs Asset Management added new position in AmerisourceBergen Corp. during the most recent quarter end. The investment management firm now holds 20,073 shares of AmerisourceBergen Corp. which is valued at $1,804,362 , the company said in a statement filed on Aug 1, 2016 with the SEC.AmerisourceBergen Corp. makes up approximately 1.12% of Trimtabs Asset Management’s portfolio.

Other Hedge Funds, Including , Nebula Capital Management Lp added ABC to its portfolio by purchasing 11,850 company shares during the most recent quarter which is valued at $1,065,197. AmerisourceBergen Corp. makes up approx 8.21% of Nebula Capital Management Lp’s portfolio. Lmr Partners Llp sold out all of its stake in ABC during the most recent quarter. The investment firm sold 3,514 shares of ABC which is valued $299,358.Pineno Levin Ford Asset Management boosted its stake in ABC in the latest quarter, The investment management firm added 12,235 additional shares and now holds a total of 65,410 shares of AmerisourceBergen Corp. which is valued at $5,616,103. AmerisourceBergen Corp. makes up approx 2.82% of Pineno Levin Ford Asset Management’s portfolio.Banced Corp reduced its stake in ABC by selling 184 shares or 3.33% in the most recent quarter. The Hedge Fund company now holds 5,346 shares of ABC which is valued at $454,036. AmerisourceBergen Corp. makes up approx 0.79% of Banced Corp’s portfolio.

AmerisourceBergen Corp. closed down -0.91 points or -1.01% at $88.98 with 18,97,447 shares getting traded on Thursday. Post opening the session at $89.71, the shares hit an intraday low of $88.44 and an intraday high of $89.81 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.

On the company’s financial health, AmerisourceBergen Corp. reported $1.37 EPS for the quarter, beating the analyst consensus estimate by $ 0.10 according to the earnings call on Aug 2, 2016. Analyst had a consensus of $1.27. The company had revenue of $36900.00 million for the quarter, compared to analysts expectations of $36705.18 million. The company’s revenue was up 7.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.20 EPS.

Many Wall Street Analysts have commented on AmerisourceBergen Corp.. Company shares were Reiterated by FBR Capital on Aug 3, 2016 to “Mkt Perform”, Firm has raised the Price Target to $ 90 from a previous price target of $84 .Company shares were Reiterated by Barclays on Aug 3, 2016 to “Equal Weight”, Firm has raised the Price Target to $ 89 from a previous price target of $83 .AmerisourceBergen Corp. was Resumed by BofA/Merrill to “Neutral” on Jun 7, 2016.

AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company operates through two segments: Pharmaceutical Distribution and Other. The Company also provides data and other services to its manufacturing customers. The Company provides services to healthcare providers and pharmaceutical and biotech manufacturers. The Company provides pharmacy services to certain specialty drug patients. Additionally the Company offers healthcare providers and pharmaceutical manufacturers with services including reimbursement and pharmaceutical consulting services logistics services inventory management pharmacy automation and pharmacy management. The Company has a distribution facility network totaling approximately 30 distribution facilities in the United States.

Leave a Reply

AmerisourceBergen Corp. - Is it time to Sell?

Top Brokerage Firms are advising their investors on AmerisourceBergen Corp.. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.